Druggability analysis and classification of protein tyrosine phosphatase active sites

被引:37
作者
Ghattas, Mohammad A. [1 ]
Raslan, Noor [1 ]
Sadeq, Asil [1 ]
Al Sorkhy, Mohammad [1 ]
Atatreh, Noor [1 ]
机构
[1] Al Ain Univ Sci & Technol, Coll Pharm, POB 64141, Al Ain, U Arab Emirates
来源
DRUG DESIGN DEVELOPMENT AND THERAPY | 2016年 / 10卷
关键词
PTP1B; oral bioavailability; drug-like inhibitors; drug design; active site; allosteric site; MPtpB; CD45; SHP2; YopH; VIRTUAL SCREENING APPROACH; STRUCTURE-BASED DESIGN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SELECTIVE INHIBITORS; INSULIN SENSITIVITY; DRUG DISCOVERY; 1B; POTENT; PTP1B;
D O I
10.2147/DDDT.S111443
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein tyrosine phosphatases (PTP) play important roles in the pathogenesis of many diseases. The fact that no PTP inhibitors have reached the market so far has raised many questions about their druggability. In this study, the active sites of 17 PTPs were characterized and assessed for its ability to bind drug-like molecules. Consequently, PTPs were classified according to their druggability scores into four main categories. Only four members showed intermediate to very druggable pocket; interestingly, the rest of them exhibited poor druggability. Particularly focusing on PTP1B, we also demonstrated the influence of several factors on the druggability of PTP active site. For instance, the open conformation showed better druggability than the closed conformation, while the tight-bound water molecules appeared to have minimal effect on the PTP1B druggability. Finally, the allosteric site of PTP1B was found to exhibit superior druggability compared to the catalytic pocket. This analysis can prove useful in the discovery of new PTP inhibitors by assisting researchers in predicting hit rates from high throughput or virtual screening and saving unnecessary cost, time, and efforts via prioritizing PTP targets according to their predicted druggability.
引用
收藏
页码:3197 / 3209
页数:13
相关论文
共 50 条
  • [41] Thiazolidinone Derivatives as Competitive Inhibitors of Protein Tyrosine Phosphatase 1B (PTP1B)
    Aher, Nilkanth G.
    Kafle, Bhooshan
    Cho, Hyeongjin
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2013, 34 (04) : 1275 - 1277
  • [42] Structure of the Trypanosoma cruzi protein tyrosine phosphatase TcPTP1, a potential therapeutic target for Chagas' disease
    Lountos, George T.
    Tropea, Joseph E.
    Waugh, David S.
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2013, 187 (01) : 1 - 8
  • [43] Novel Mixed-Type Inhibitors of Protein Tyrosine Phosphatase 1B. Kinetic and Computational Studies
    Jazmin Sarabia-Sanchez, Marie
    Josue Trejo-Soto, Pedro
    Miguel Velazquez-Lopez, Jose
    Carvente-Garcia, Carlos
    Castillo, Rafael
    Hernandez-Campos, Alicia
    Avitia-Dominguez, Claudia
    Enriquez-Mendiola, Daniel
    Sierra-Campos, Erick
    Valdez-Solana, Monica
    Manuel Salas-Pacheco, Jose
    Tellez-Valencia, Alfredo
    MOLECULES, 2017, 22 (12):
  • [44] Multiple graph alignment for the structural analysis of protein active sites
    Weskamp, Nils
    Huellermeier, Eyke
    Kuhn, Daniel
    Klebe, Gerhard
    IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2007, 4 (02) : 310 - 320
  • [45] Analysis of in vitro interactions of protein tyrosine phosphatase 1B with insulin receptors
    Wang, XY
    Bergdahl, K
    Heijbel, A
    Liljebris, C
    Bleasdale, JE
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 173 (1-2) : 109 - 120
  • [46] Analysis of water patterns in protein kinase binding sites
    Barillari, Caterina
    Duncan, Anna L.
    Westwood, Isaac M.
    Blagg, Julian
    van Montfort, Rob L. M.
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2011, 79 (07) : 2109 - 2121
  • [47] The crystal structure of human receptor protein tyrosine phosphatase κ phosphatase domain 1
    Eswaran, Jeyanthy
    Debreczeni, Judit .
    Longman, Emma
    Barr, Alastair J.
    Knapp, Stefan
    PROTEIN SCIENCE, 2006, 15 (06) : 1500 - 1505
  • [48] Protein Tyrosine Phosphatase 1B Regulates Pyruvate Kinase M2 Tyrosine Phosphorylation
    Bettaieb, Ahmed
    Bakke, Jesse
    Nagata, Naoto
    Matsuo, Kosuke
    Xi, Yannan
    Liu, Siming
    AbouBechara, Daniel
    Melhem, Ramzi
    Stanhope, Kimber
    Cummings, Bethany
    Graham, James
    Bremer, Andrew
    Zhang, Sheng
    Lyssiotis, Costas A.
    Zhang, Zhong-Yin
    Cantley, Lewis C.
    Havel, Peter J.
    Haj, Fawaz G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (24) : 17360 - 17371
  • [49] Protein tyrosine phosphatase inhibitors: a patent review and update (2012-2023)
    Kelam, Lakshmi Mounika
    Chhabra, Vaishnavi
    Dhiman, Sarika
    Kumari, Deevena
    Sobhia, M. Elizabeth
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2024, 34 (04) : 187 - 209
  • [50] T Cell Protein Tyrosine Phosphatase in Glucose Metabolism
    Wang, Ya-nan
    Liu, Shiyue
    Jia, Tingting
    Feng, Yao
    Xu, Xin
    Zhang, Dongjiao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9